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Neonatal Group B Streptococcus (GBS) infection can
be life threatening. Recognizing this as an important pre-
ventable disease, the CDC issued speciﬁc guidelines in 1996.
Compelling evidence for a strong protective effect of the
screening-based strategy relative to the risk-based strat-
egy led to new recommendations in 2002 for universal
screening by vaginal-rectal culture. However, in Louisiana,
there is no uniform strategy for GBS control. This study
was therefore undertaken as a pilot study for needs assess-
ment to formulate public health policy. The initial phase of
this project involved the development of a comprehensive
questionnaire. The second phase involved administration
of this survey instrument to consenting OB/GYN clinics.
The ﬁnal phase involved statistical analysis using SPSS.
Although almost all clinics did universal screening of preg-
nant women, only 70.6% used laboratory-based screening.
Despite recommendations against routine prophylaxis for
low-risk deliveries, 57% of planned C sections involved pro-
phylaxis. Only 51.5% of respondents provided prophylaxis
for women with prior infants with GBS disease. As recom-
mended, most clinics performed culture-based screening
at 35—37 weeks (91.2%), undertook both vaginal and rec-
tal cultures (70.6%), and cultured the lower vagina (69.7%)
instead of the cervix (23.3%). In the risk-based approach,
clinics used recommended high-risk determinants as follows:
gestation below 37 weeks (92.3%) membrane rupture over
18 hours (76.9%); temperature over 100.4 ◦F (73.1%). If cul-
ture screening result is unknown at labor, chemoprophylaxis
should be based on risk. Only 25% complied with this recom-
mendation. Only 64.3% of respondents treated infection and
gave prophylaxis during labor if GBS is isolated from mater-
nal urine. When overall compliance was stratiﬁed using the
number of recommendations met out of a total of thir-
teen, 16.7% of institutions showed high compliance, 52.8%
medium, and 30.6% low. This study demonstrates that GBS
control is less than optimal in Louisiana and necessitates
uniform statewide policy to address this need.
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Background: A heptavalent protein conjugate pneu-
mococccal vaccine has been developed and, recently, is
licenced also in Korea. It is important to know the preva-
lence of each serotype of pneumococci in the particular
countries where the vaccine is used to estimate the coverage
rate by the vaccine.
Methods: One hundred and twenty-seven strains of clin-
ical isolates and 72 strains from healthy carriers that were
recovered from Korean children during the period from 2001
to 2006 were subjected to determination of serotype by
Quellung reaction and penicillin susceptibility with oxacillin
disc diffusion test.
Results: Forty-three percent of clinical isolates were
obtained from children under 2 years of age. Thirty strains
(24%) were isolated from normally sterile body ﬂuids, such
as blood (15 strains), cerebrospinal ﬂuid (6), ascitic ﬂuid (1)
and closed pus (4). Other sources of the specimens included
throat or nasal swab (33 strains), lower respiratory secre-
tions such as sputum (16) or transtracheal aspirates (9), ear
discharge (33), and others (6). The frequent serotypes were
19F (24% of the isolates), 19A (17%), 23F (15%), 6A (11%),
6B (7%) and 9V (6%). Fifty six percent of the clinical isolates
were represented in the 7-valent vaccine, and 84% when
the cross-reactive serotypes were included. Carrier study
was done for 1 to 5 year-old children. Among the strains iso-
lated from carriers, the frequent serotypes were 19F (31%),
14 (21%), 11A (13%), 23F (11%), 18C (6%), and 19A (4%).
Seventy-one percent of the carrier strains were included
in the 7-valent vaccine, and 78% when the cross-reactive
serotypes were included. Ninety four percent of the clinical
isolates and 86% of carrier strains were not susceptible the
penicillin.
Conclusion: 56—71% of pneumococci recovered from
Korean children are covered by the 7-valent vaccine and the
prevalence of penicillin resistance was very high.
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